We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+35.85%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$6.88B
AUM Growth
+$1.73B
Cap. Flow
+$902M
Cap. Flow %
13.11%
Top 10 Hldgs %
21.84%
Holding
2,268
New
850
Increased
454
Reduced
380
Closed
429

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$31.5M
2
HZO icon
MarineMax
HZO
+$17.5M
3
HPE icon
Hewlett Packard
HPE
+$17.2M
4
AS icon
Amer Sports
AS
+$16.9M
5
MCD icon
McDonald's
MCD
+$16.9M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$48.3M
2
COST icon
Costco
COST
+$21.8M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$18.5M
4
TSM icon
TSMC
TSM
+$16.9M
5
ABVX
Abivax
ABVX
+$16.7M

Sector Composition

Rank Sector Weight
1 Technology 10.41%
2 Consumer Discretionary 7.88%
3 Healthcare 7.8%
4 Industrials 6.9%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
O icon
1626
Realty Income
O
$58.5B
$203K ﹤0.01%
+3,336
New +$194K
SLM icon
1627
SLM Corp
SLM
$5.17B
$202K ﹤0.01%
+7,305
New +$228K
BTAL icon
1628
AGF US Market Neutral Anti-Beta Fund
BTAL
$300M
$201K ﹤0.01%
+12,632
New +$208K
BRK.B icon
1629
CALL
Berkshire Hathaway Class B
BRK.B
$1.12T
$201K ﹤0.01%
+400
New +$194K
MU icon
1630
PUT
Micron Technology
MU
$1.01T
$201K ﹤0.01%
1,200
-69,800
-98% -$8.93M
BIO icon
1631
Bio-Rad Laboratories Class A
BIO
$9.3B
$201K ﹤0.01%
716
-6,180
-90% -$1.68M
NUS icon
1632
Nu Skin
NUS
$253M
$199K ﹤0.01%
+16,352
New +$172K
LYEL icon
1633
Lyell Immunopharma
LYEL
$328M
$199K ﹤0.01%
12,234
– –
CURI icon
1634
CuriosityStream
CURI
$154M
$198K ﹤0.01%
+37,305
New +$172K
DCGO icon
1635
DocGo
DCGO
$61.8M
$197K ﹤0.01%
144,534
-41,156
-22% -$62.3K
NTST
1636
NETSTREIT Corp
NTST
$2.06B
$196K ﹤0.01%
+10,857
New +$196K
HR icon
1637
Healthcare Realty
HR
$7.06B
$196K ﹤0.01%
10,863
-8,154
-43% -$138K
BMBL icon
1638
Bumble
BMBL
$399M
$195K ﹤0.01%
+32,043
New +$219K
CLOV icon
1639
Clover Health Investments
CLOV
$2.18B
$193K ﹤0.01%
+63,150
New +$180K
LAKE icon
1640
Lakeland Industries
LAKE
$123M
$192K ﹤0.01%
+12,953
New +$189K
GLV
1641
Clough Global Dividend & Income Fund
GLV
$78.1M
$189K ﹤0.01%
31,839
– –
MRTN icon
1642
Marten Transport
MRTN
$1.22B
$189K ﹤0.01%
+17,736
New +$216K
MOBBW
1643
Mobilicom Ltd Warrants
MOBBW
$2.39B
$189K ﹤0.01%
20,300
– –
PERI icon
1644
Perion Network
PERI
$378M
$188K ﹤0.01%
+19,633
New +$196K
IMSRW
1645
Terrestrial Energy Warrant
IMSRW
$28.8M
$188K ﹤0.01%
+11,476
New +$32K
NWL icon
1646
Newell Brands
NWL
$2.63B
$188K ﹤0.01%
+35,905
New +$203K
AEVA
1647
Aeva Technologies
AEVA
$1.34B
$187K ﹤0.01%
+12,891
New +$244K
WSR
1648
DELISTED
Whitestone REIT
WSR
$185K ﹤0.01%
+15,089
New +$190K
SNCY
1649
DELISTED
Sun Country Airlines
SNCY
$185K ﹤0.01%
+15,686
New +$194K
MD icon
1650
Pediatrix Medical
MD
$2.13B
$180K ﹤0.01%
+10,718
New +$161K
64 65
66
67 68

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, Boothbay Fund Management held 2,268 positions worth $6.88B, up 34% from $5.15B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Boothbay Fund Management deployed $902M of net new capital in Q3 2025, opening 850 new positions and adding to 454 existing holdings. Its largest new stake was MarineMax: 685,838 shares worth $17.4M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Verona Pharma, an estimated $48.3M trimmed.

  • Boothbay Fund Management's largest Q3 2025 buy was MarineMax: 685,838 shares worth $17.4M.
  • Boothbay Fund Management added most to Walmart Inc in Q3 2025, an estimated $31.5M increase.
  • Boothbay Fund Management's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $48.3M.
  • Boothbay Fund Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, selling an estimated $18.5M.
  • Boothbay Fund Management's ten largest holdings make up 22% of its $6.88B portfolio in Q3 2025.
  • Boothbay Fund Management opened 850 new positions and closed 429 in Q3 2025.
  • Boothbay Fund Management's portfolio value rose 34% quarter-over-quarter to $6.88B.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.